Provided by Tiger Fintech (Singapore) Pte. Ltd.

GH Research PLC

13.70
+1.209.60%
Post-market: 13.700.00000.00%19:52 EDT
Volume:204.35K
Turnover:2.75M
Market Cap:849.79M
PE:-17.42
High:14.00
Open:12.63
Low:12.53
Close:12.50
Loading ...

Dow Falls 150 Points; ISM Manufacturing PMI Rises In January

Benzinga
·
04 Feb

S&P 500 Down Over 1%; Tyson Foods Posts Upbeat Results

Benzinga
·
03 Feb

GH Research Shares Jump After Positive Phase 2B Trial Results

Dow Jones
·
03 Feb

GH Research Shares Rise 85% After Depression Drug Meets Main Goal in Mid-Stage Study

THOMSON REUTERS
·
03 Feb

Sector Update: Health Care Stocks Lean Lower Premarket Monday

MT Newswires Live
·
03 Feb

Wall Street on Edge Amid Trump Tariffs, Driving Premarket Losses for US Equity Futures

MT Newswires Live
·
03 Feb

BUZZ-GH Research jumps as depression therapy meets mid-stage trial goals

Reuters
·
03 Feb

Top Premarket Gainers

MT Newswires Live
·
03 Feb

GH Research Shares Soar 90% Pre-Bell After Trial of GH001 to Treat Depression Meets All Endpoints

MT Newswires Live
·
03 Feb

GH Research Shares Climb 86.7% Premarket After Depression Drug Meets Main Goal in Mid-Stage Study

THOMSON REUTERS
·
03 Feb

GH Research announces primary endpoint met in Phase 2b trial of GH001

TIPRANKS
·
03 Feb

GH Research Announces Primary Endpoint Met in Phase 2B Trial With GH001 in Trd Demonstrating -15.5 Point Placebo-Adjusted Madrs Reduction

THOMSON REUTERS
·
03 Feb

GH Research Plc - All Secondary Endpoints Met With Significant Improvements on Day 8

THOMSON REUTERS
·
03 Feb

GH Research Plc - GH001 Well Tolerated With No Serious Adverse Events Reported

THOMSON REUTERS
·
03 Feb

GH Research Shares Rise Ahead of Release of Clinical-Trial Results

Dow Jones
·
01 Feb

GH Research to Provide Update on Phase 2B Trial With GH001 in Trd

THOMSON REUTERS
·
01 Feb

GH Research Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
27 Jan

GH Research Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Jan

BUZZ-GH Research rises as lead drug meets main goal in mid-stage studies

Reuters
·
10 Jan

GH Research Plc - Full Response to Ind Hold Planned for Mid-2025

THOMSON REUTERS
·
10 Jan